0001213900-18-014092.txt : 20181018
0001213900-18-014092.hdr.sgml : 20181018
20181018165106
ACCESSION NUMBER: 0001213900-18-014092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181018
FILED AS OF DATE: 20181018
DATE AS OF CHANGE: 20181018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J
CENTRAL INDEX KEY: 0001068029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 181128721
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER NAME:
FORMER CONFORMED NAME: SCHABER CHRISTOPHER
DATE OF NAME CHANGE: 19980811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2018-10-18
0
0000812796
SOLIGENIX, INC.
SNGX
0001068029
SCHABER CHRISTOPHER J
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
1
1
0
0
Chairman, CEO and President
Common Stock
2018-10-18
4
P
0
8700
1.1698
A
37325
D
This transaction was executed in multiple trades at prices ranging from $1.16 to $1.17. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Christopher J. Schaber
2018-10-18